BioNTech-Pfizer
14 Nov 2021
Younger people have a higher risk of heart inflammation with a Moderna shot, the country's vaccine advisory committee has said. It also advises on the BioNTech-Pfizer vaccine to all pregnant women.
25 Oct 2021
BioNTech and Pfizer and said their vaccine is highly effective among children in the 5-11-year age group. Follow DW for the latest.
6 Oct 2021
While the European Medicines Agency approved a third dose for people over 18-years-old, the agency said it was up to member states to decide whether to use them.
2 Oct 2021
The FDA's limited approval comes weeks after US President Joe Biden's administration announced a sweeping plan that would allow nearly all American adults to get a third shot.
2 Oct 2021
The BioNTech/Pfizer vaccine for 5 to 11 year olds could be approved in the US as early as October. Meanwhile, Australia plans to stop paying workers affected by lockdowns. Follow DW for the latest.
13 Jul 2021
BioNTech and Pfizer said an extra dose of their jab could boost immunity against the coronavirus delta variant. South Korea raised pandemic restrictions as cases hit the "maximum crisis level." Follow DW for the latest.
13 May 2021
The CDC has given a green light to using the BioNTech-Pfizer vaccine in children aged 12 to 15. Meanwhile, Cuba has started inoculating its citizens using two locally produced vaccines. Follow DW for the latest.
6 May 2021
The FDA is expected to approve the BioNTech-Pfizer COVID-19 vaccine for adolescents between the ages of 12 and 15 next week, according to media reports. DW has the latest.
26 Apr 2021
Brussels says its third contract with the US-German vaccine consortium is the world's largest supply deal so far to stem the coronavirus' spread.
19 Mar 2021
EU chief Ursula von der Leyen says expediting 10 million doses will give Member States "room to maneuver," after several EU countries halted the use of the AstraZeneca shot.
14 Feb 2021
The EU's vaccine rollout has come under fire for its slow pace amid production shortages. BioNTech-Pfizer now plans on supplying around 2 billion total doses, up from a previous 1.3 billion, by the end of 2021.
14 Feb 2021
A lab study has found the vaccine effective against UK and South Africa variants. German Health Minister Jens Spahn has voiced his confidence in the EU's three approved vaccines.